Instil Bio (TIL) Assets Average (2021 - 2026)
Instil Bio (TIL) posted Assets Average of $199.1 million for Q2 2026, down 1.44% on a QoQ basis from $202.0 million in Q1 2026, and down 15.01% year-over-year from $234.2 million in Q2 2025.
Analysis
Instil Bio (TIL) Assets Average (2021 - 2026) Analysis & Trends
Instil Bio has reported Assets Average for 6 years, with the latest figure at $199.1 million in Q2 2026.
- On a quarterly basis, Assets Average fell 15.01% year-over-year to $199.1 million in Q2 2026; TTM through Jun 2026 was $199.1 million, a 15.01% decrease from a year earlier, with the FY2025 full-year figure at $233.5 million, down 20.72% from the prior year.
- Assets Average was $199.1 million for Q2 2026 at Instil Bio, down from $202.0 million in the prior quarter.
- The five-year high for Assets Average was $587.5 million in Q1 2022, with the low at $199.1 million in Q2 2026.
- Average Assets Average over 5 years is $348.6 million, with a median of $308.1 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Assets Average advanced 15.74% in 2022, then slumped 34.39% in 2023.
- Over 5 years, Assets Average stood at $507.4 million in 2022, then plunged by 34.39% to $333.0 million in 2023, then slipped by 19.49% to $268.1 million in 2024, then decreased by 22.54% to $207.6 million in 2025, then fell by 4.13% to $199.1 million in 2026.
- The last three Assets Average figures came in at $199.1 million (Q2 2026), $202.0 million (Q1 2026), and $207.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - | 199.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 199.07 Mn |
| Mar 31, 2026 | 201.98 Mn |
| Dec 31, 2025 | 207.65 Mn |
| Sep 30, 2025 | 221.38 Mn |
| Jun 30, 2025 | 234.22 Mn |
| Mar 31, 2025 | 250.51 Mn |
| Dec 31, 2024 | 268.06 Mn |
| Sep 30, 2024 | 283.44 Mn |
| Jun 30, 2024 | 300.31 Mn |
| Mar 31, 2024 | 315.97 Mn |
| Dec 31, 2023 | 332.95 Mn |
| Sep 30, 2023 | 374.29 Mn |
| Jun 30, 2023 | 417.74 Mn |
| Mar 31, 2023 | 454.65 Mn |
| Dec 31, 2022 | 507.43 Mn |
| Sep 30, 2022 | 550.64 Mn |
| Jun 30, 2022 | 566.74 Mn |
| Mar 31, 2022 | 587.46 Mn |
| Dec 31, 2021 | 628.69 Mn |
| Sep 30, 2021 | 660.03 Mn |